Clinical Trial Update: Vitamin D3 and the Stress-axis in MS [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Vitamin D3's effect on the stress-axis in multiple sclerosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Academic MS Center Limburg | Conditions: Multiple Sclerosis | Phase 2 | Status: TERMINATED